Brendan C. Lanpher

4.3k total citations
41 papers, 1.2k citations indexed

About

Brendan C. Lanpher is a scholar working on Molecular Biology, Genetics and Clinical Biochemistry. According to data from OpenAlex, Brendan C. Lanpher has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Genetics and 13 papers in Clinical Biochemistry. Recurrent topics in Brendan C. Lanpher's work include Metabolism and Genetic Disorders (13 papers), Genomics and Rare Diseases (9 papers) and Mitochondrial Function and Pathology (7 papers). Brendan C. Lanpher is often cited by papers focused on Metabolism and Genetic Disorders (13 papers), Genomics and Rare Diseases (9 papers) and Mitochondrial Function and Pathology (7 papers). Brendan C. Lanpher collaborates with scholars based in United States, Germany and France. Brendan C. Lanpher's co-authors include Katharine H. Dixon, Jason Chiu, Kane L. Kelley, Kenneth H. Cowan, Nicola Brunetti‐Pierri, Brendan Lee, LaDonna Immken, Ankita Patel, Paweł Stankiewicz and Gayle Patel and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and SHILAP Revista de lepidopterología.

In The Last Decade

Brendan C. Lanpher

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brendan C. Lanpher United States	17	581	465	259	175	120	41	1.2k
Zuhair N. Al‐Hassnan Saudi Arabia	18	549 0.9×	248 0.5×	291 1.1×	114 0.7×	107 0.9×	78	1.0k
Lock Hock Ngu Malaysia	18	503 0.9×	242 0.5×	299 1.2×	113 0.6×	151 1.3×	59	899
Elżbieta Ciara Poland	17	647 1.1×	278 0.6×	218 0.8×	95 0.5×	78 0.7×	88	1.1k
David Coman Australia	20	583 1.0×	227 0.5×	302 1.2×	149 0.9×	129 1.1×	79	1.2k
Amal Alhashem Saudi Arabia	19	616 1.1×	447 1.0×	163 0.6×	67 0.4×	111 0.9×	76	1.1k
Bruno Maranda Canada	23	714 1.2×	394 0.8×	260 1.0×	129 0.7×	152 1.3×	57	1.4k
Faiqa Imtiaz Saudi Arabia	17	601 1.0×	398 0.9×	139 0.5×	73 0.4×	70 0.6×	74	1.1k
Jozef Hertecant United Arab Emirates	19	498 0.9×	210 0.5×	203 0.8×	67 0.4×	70 0.6×	50	995
Yongguo Yu China	20	649 1.1×	540 1.2×	153 0.6×	85 0.5×	117 1.0×	110	1.2k
Callum Wilson New Zealand	21	956 1.6×	241 0.5×	495 1.9×	174 1.0×	104 0.9×	58	1.6k

Countries citing papers authored by Brendan C. Lanpher

Since Specialization

Citations

This map shows the geographic impact of Brendan C. Lanpher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brendan C. Lanpher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brendan C. Lanpher more than expected).

Fields of papers citing papers by Brendan C. Lanpher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brendan C. Lanpher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brendan C. Lanpher. The network helps show where Brendan C. Lanpher may publish in the future.

Co-authorship network of co-authors of Brendan C. Lanpher

This figure shows the co-authorship network connecting the top 25 collaborators of Brendan C. Lanpher. A scholar is included among the top collaborators of Brendan C. Lanpher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brendan C. Lanpher. Brendan C. Lanpher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wirrell, Elaine, et al.. (2024). Epilepsy with Eyelid Myoclonia Associated with CHD2 Variants: Report of Two Cases (P7-1.002). Neurology. 102(17_supplement_1).

Vairo, Filippo Pinto e, Elaine Wirrell, Lily C. Wong‐Kisiel, et al.. (2024). CHD2‐related epilepsy with eyelid myoclonia: Report of three cases. Epileptic Disorders. 27(1). 90–95.

Pillai, Nishitha R., Alia Ahmed, Amy Hietala, et al.. (2023). Disparities in late and lost: Pediatricians' role in following Pompe disease identified by newborn screening. Molecular Genetics and Metabolism. 140(1-2). 107633–107633. 2 indexed citations

Lanpher, Brendan C., et al.. (2022). Pediatric manifestations of Lynch Syndrome: A single center experience. SHILAP Revista de lepidopterología. 86. 102431–102431. 2 indexed citations

Macke, Erica L., Joel A. Morales‐Rosado, Aditi Gupta, et al.. (2020). A novel missense variant and multiexon deletion causing a delayed presentation of xeroderma pigmentosum, group C. Molecular Case Studies. 6(4). a005165–a005165. 1 indexed citations

Blackburn, Patrick R., Matthew Schultz, Dong Li, et al.. (2020). Expanding the clinical and phenotypic heterogeneity associated with biallelic variants in ACO2. Annals of Clinical and Translational Neurology. 7(6). 1013–1028. 5 indexed citations

Hayeems, Robin Z., David Dimmock, David Bick, et al.. (2020). Clinical utility of genomic sequencing: a measurement toolkit. npj Genomic Medicine. 5(1). 56–56. 46 indexed citations

Schultz‐Rogers, Laura, Karthik Muthusamy, Filippo Pinto e Vairo, Eric W. Klee, & Brendan C. Lanpher. (2020). Novel loss-of-function variants in TRIO are associated with neurodevelopmental disorder: case report. BMC Medical Genetics. 21(1). 219–219. 7 indexed citations

Cho, Janice, Joseph C. Y. Chen, Jonas Paludo, et al.. (2019). Hyperammonemic encephalopathy in a patient with fibrolamellar hepatocellular carcinoma: case report and literature review. Journal of Gastrointestinal Oncology. 10(3). 582–588. 12 indexed citations

10.

Adam, Margaret P, Siddharth Banka, Hans T. Björnsson, et al.. (2018). Kabuki syndrome: international consensus diagnostic criteria. Journal of Medical Genetics. 56(2). 89–95. 130 indexed citations

11.

Gall, Émilie Cornec-Le, Fouad T. Chebib, Charles D. Madsen, et al.. (2018). The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 Mutations. American Journal of Kidney Diseases. 72(2). 302–308. 24 indexed citations

12.

Vairo, Filippo Pinto e, Nicole J. Boczek, Margot A. Cousin, et al.. (2017). The prevalence of diseases caused by lysosome-related genes in a cohort of undiagnosed patients. Molecular Genetics and Metabolism Reports. 13. 46–51. 17 indexed citations

13.

Smpokou, Patroula, Brendan C. Lanpher, & Kenneth N. Rosenbaum. (2015). Important Considerations in the Initial Clinical Evaluation of the Dysmorphic Neonate. Advances in Neonatal Care. 15(4). 248–252. 1 indexed citations

14.

Nagamani, Sandesh C.S., Oleg A. Shchelochkov, Susan Carter, et al.. (2012). A randomized controlled trial to evaluate the effects of high-dose versus low-dose of arginine therapy on hepatic function tests in argininosuccinic aciduria. Molecular Genetics and Metabolism. 107(3). 315–321. 22 indexed citations

15.

Arnold, Georgianne L., Denise Salazar, Julie Neidich, et al.. (2012). Outcome of infants diagnosed with 3-methyl-crotonyl-CoA-carboxylase deficiency by newborn screening. Molecular Genetics and Metabolism. 106(4). 439–441. 18 indexed citations

16.

Marini, Juan C., Brendan C. Lanpher, Fernando Scaglia, et al.. (2011). Phenylbutyrate improves nitrogen disposal via an alternative pathway without eliciting an increase in protein breakdown and catabolism in control and ornithine transcarbamylase–deficient patients. American Journal of Clinical Nutrition. 93(6). 1248–1254. 9 indexed citations

17.

Solomon, Benjamin D., Daniel Pineda‐Alvarez, Donald W. Hadley, et al.. (2011). Personalized genomic medicine: Lessons from the exome. Molecular Genetics and Metabolism. 104(1-2). 189–191. 11 indexed citations

18.

Shinawi, Marwan, Christian P. Schaaf, Samarth Bhatt, et al.. (2009). A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes. Nature Genetics. 41(12). 1269–1271. 141 indexed citations

19.

El‐Hattab, Ayman W., Teresa A. Smolarek, Elizabeth K. Schorry, et al.. (2009). Redefined genomic architecture in 15q24 directed by patient deletion/duplication breakpoint mapping. Human Genetics. 126(4). 589–602. 56 indexed citations

20.

Brunetti‐Pierri, Nicola, Viraj Mane, Donna Palmer, et al.. (2008). Phenotypic correction of ornithine transcarbamylase deficiency using low dose helper‐dependent adenoviral vectors. The Journal of Gene Medicine. 10(8). 890–896. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact